Sign in

CIK 0001829802 · <br>Emerging growth company

Faeth Therapeutics, Inc.

Sign in to watch
Ticker
FTH
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
512-200-2982
Business address
701 TILLERY STREET #12 #1010, AUSTIN, TX, 78702
Former names
Sensei Biotherapeutics, Inc.
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Open-market sale 10% owner sold 25,000 shares at an average $20.02 ($500,543)
  4. 4 Open-market sale 10% owner sold 25,000 shares at an average $20.02 ($500,543)
  5. 4 Open-market sale 10% owner sold 17,076 shares at an average $31.51 ($538,114)
  6. 4 Open-market buy 10% owner bought 12,180 shares at an average $31.37 ($382,100)
  7. 4 Open-market buy 10% owner bought 30,585 shares at an average $26.75 ($818,257)
  8. 3 Insider Initial Statement of Ownership
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 3 Insider Initial Statement of Ownership
  13. 4 Derivatives Options or other derivatives
  14. 3 Insider Initial Statement of Ownership
  15. 4 Open-market sale 10% owner sold 6,612 shares at an average $8.25 ($54,575)
  16. 4 Open-market sale 10% owner sold 6,612 shares at an average $8.25 ($54,575)
  17. 4 Open-market sale 10% owner sold 21,295 shares at an average $10.93 ($232,690)
  18. 4 Open-market sale 10% owner sold 21,295 shares at an average $10.93 ($232,690)
  19. 3 Insider Initial Statement of Ownership
  20. 4 Derivatives Options or other derivatives

Page 2 of 13 · 245 filings